Daxor Corporation announced it has entered into an industry partnership with MedAxiom, an American College of Cardiologycompany, to amplify awareness and adoption of Daxor's blood volume analysis (BVA) technology to achieve healthcare's Quadruple Aim of better outcomes, lower costs, improved patient experience and improved clinician experience.